Condition
Diabetic Macular Edema clinical trials and research
As of November 12, 2026, Find a Trial lists 19 Diabetic Macular Edema clinical trials that are recruiting, at sites in 12 countries (most in United States (6), China (4), Sweden (2)). By phase: Phase 1 (5), Phase 2 (3), Phase 1/2 (3), Phase 4 (1). The most active sponsors are Vastra Gotaland Region (2), Frontera Therapeutics (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 19Clinical trials
- 12Countries
Newest Diabetic Macular Edema clinical trials
All recruiting trials (19)
-
Blepharoptosis After Repeated Anti-VEGF Injections in One Eye
This study tests whether repeated intravitreal anti-VEGF injections in one eye affect eyelid position compared with the untreated fellow eye.
-
Testing Different Doses of BI 3812465 in Diabetic Macular Edema
Researchers are testing whether varying doses of BI 3812465 can be tolerated in adults with center-involved diabetic macular edema.
-
Comparing AVT29 and Eylea HD for diabetic macular edema
This study will test whether AVT29 works as well and is as safe as Eylea HD in adults with center-involving diabetic macular edema who have reduced vision.
-
Daily oral Kamuvudine-9 (K9) for diabetic macular edema
This trial will test whether taking oral K9 twice daily is safe and improves vision in adults with diabetic macular edema.
-
RO7823653 injections, alone or with faricimab, for diabetic macular edema
This research tests injections of RO7823653, given alone or with faricimab, in people with diabetic macular edema to see if the medication is safe and how the eye handles it.
-
Lactobacillus plantarum 299v Probiotic for Diabetic Macular Edema
A probiotic pill taken twice daily for four months is tested to see if it can help people with diabetic macular edema see better or need fewer eye injections.
-
Early progression of non-center diabetic macular edema after phacoemulsification
This will see if non-center-involving diabetic macular edema worsens in the early weeks after cataract surgery in adults with diabetes.
-
Blood and OCT biomarkers in people with diabetic macular edema receiving anti-VEGF or dexamethasone implant
This project will test whether blood markers and OCT imaging signs can predict how people with diabetic macular edema respond to anti-VEGF injections or a dexamethasone eye implant.
-
Gene therapy for diabetic macular edema in adults
This study is testing a new gene therapy called RGX-314 to see if it can improve vision in adults with diabetic macular edema compared to the standard treatment.
-
Testing THN391 for Diabetic Macular Edema
This study is testing a new drug called THN391 to see if it can safely help people with diabetic macular edema caused by diabetes.
-
Home-based monitoring for diabetic macular edema treatment
This study is testing if using home-based monitoring tools can help people with diabetic macular edema keep their vision stable while reducing the need for frequent trips to the clinic.
-
Comparing single-session and multiple-session laser treatment for diabetic eye disease
This study is testing whether one session or multiple sessions of laser treatment works better for people with newly diagnosed diabetic eye disease to help them keep their vision and avoid complications.
-
Gene therapy for diabetic macular edema
This study is testing a new gene therapy injection to see if it can improve vision and eye health in people with diabetic macular edema.
-
Gene therapy for diabetic macular edema
This study is testing a new gene therapy to see if it can help people with diabetic macular edema improve their vision and reduce the number of treatments they need.
-
Assessing OCU200 for Diabetic Macular Edema
This study is testing a new treatment called OCU200 to see if it can help people with diabetic macular edema while keeping them safe.
-
Comparing two eye implants for treating resistant diabetic macular edema
This study tests which of two eye implants can help people with stubborn diabetic macular edema see better and improve their eye health.
-
Treatment for diabetic retinopathy with MS-553
This study is testing a new oral medication called MS-553 to see if it can improve vision and reduce swelling in the eyes of people with diabetic retinopathy.
-
Levosulpiride treatment for diabetic eye conditions
This study is testing if a medication called levosulpiride can help improve eye problems caused by diabetes in people aged 40 to 69.
-
Switching from ranibizumab to aflibercept for eye conditions
This study is testing if switching patients with certain eye conditions from one medication to another can help improve their vision.
Related topics
Quick answers
How many Diabetic Macular Edema clinical trials are recruiting right now?
19, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 12 countries. The most sites are in United States (6 trials), China (4 trials), Sweden (2 trials), Mexico (1 trial), Turkey (Türkiye) (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 5, Phase 2: 3, Phase 1/2: 3, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.